Palatin Technologies
PTN
#9923
Rank
A$58.95 M
Marketcap
A$34.63
Share price
4.59%
Change (1 day)
2,301.48%
Change (1 year)

Market capitalization of Palatin Technologies (PTN)

Market cap: A$58.95 Million

As of December 2025 Palatin Technologies has a market cap of A$58.95 Million. This makes Palatin Technologies the world's 9923th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Palatin Technologies from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025A$58.95 M40.85%
2024A$41.85 M-47.84%
2023A$80.24 M106.03%
2022A$38.95 M-76.14%
2021A$0.16 B-19.25%
2020A$0.20 B-21.04%
2019A$0.25 B25.39%
2018A$0.20 B-2.47%
2017A$0.20 B123.94%
2016A$93.49 M50.78%
2015A$62 M67.35%
2014A$37.05 M14.89%
2013A$32.25 M43.44%
2012A$22.48 M64.36%
2011A$13.67 M-13.17%
2010A$15.75 M-60.19%
2009A$39.57 M258.38%
2008A$11.04 M-43.34%
2007A$19.49 M-89.42%
2006A$0.18 B-30.01%
2005A$0.26 B41.73%
2004A$0.18 B21.58%
2003A$0.15 B53.3%
2002A$99.62 M-24.84%
2001A$0.13 B102.08%
2000A$65.59 M134.76%
1999A$27.94 M-19.06%
1998A$34.51 M25.02%
1997A$27.61 M768.94%
1996A$3.17 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Palatin Technologies was reported to be:

A$57.18 Million
by Nasdaq info icon info icon
A$58.95 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
A$0.11 B 95.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A$15.25 M-74.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$23.34 B 39,493.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$2.76 B 4,589.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$5.47 B 9,191.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.48 B 7,503.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$732.43 B 1,242,213.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$2.18 B 3,610.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$420.95 B 713,889.44%๐Ÿ‡ฌ๐Ÿ‡ง UK